Full Press Release Details
NEW YORK , Sept. 9, 2014 /PRNewswire/ -- This week, Johnson & Johnson will host events to celebrate the work of the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research . Drs. Emmanuelle Charpentier and Jennifer Doudna will be honored for their breakthrough discovery of the CRISPR-Cas9 method of genetic editing that has led to a substantial leap in scientists' ability to manipulate genetic processes and has the potential to make a significant impact on drug development and treatment of human genetic disorders.
"The research of Drs. Doudna and Charpentier has revolutionized the field of DNA editing and microbiology, and holds great promise for the development of new medicines and the potential to make a significant impact on human health, which is at the very heart of Dr. Paul's legacy, as well as our mission at Johnson & Johnson," said Paul Stoffels , M.D., Chief Scientific Officer, Johnson & Johnson.
The events will engage the scientific community and the general public in dialogue about the significance of this research and its future applications, as well as the role of women in science, the importance of STEM education, and the role of collaboration in advancing medical innovation.
Wednesday, September 10, 2014
Thursday, September 11, 2014
About the Award Winners Dr. Emmanuelle Charpentier is Alexander von Humboldt Professor at Hannover Medical School (MHH), Head of the Department "Regulation in Infection Biology" at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany , and Guest Professor at The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umea University.
Dr. Jennifer Doudna is a Howard Hughes Medical Institute Investigator, the Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, and Professor of Biochemistry, Biophysics and Structural Biology at the University of California, Berkeley .
About The Dr. Paul Janssen Award for Biomedical Research Known to his colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted and passionate researchers. He helped save millions of lives through his contribution to the discovery and development of more than 80 medicines, four of which remain on the World Health Organization's list of essential medicines. The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson to honor the memory of Dr. Paul. Past winners include Craig C. Mello , Marc Feldmann and Sir Ravinder Maini , Axel Ullrich , Erik De Clercq and Anthony S. Fauci , Napoleone Ferrara , and Victor Ambros and Gary Ruvkun , and David Julius . Learn more at www.pauljanssenaward.com .
About Johnson & Johnson Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. For more information, visit www.jnj.com .
Contact: Seema Kumar Johnson & Johnson 908-405-1144 or [email protected]
Diane Pressman Janssen Global Services, LLC 908-295-0857 or [email protected]
SOURCE Johnson & Johnson